Renu Garg

1.5k total citations
45 papers, 977 citations indexed

About

Renu Garg is a scholar working on Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, Renu Garg has authored 45 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 11 papers in Cardiology and Cardiovascular Medicine and 7 papers in Anesthesiology and Pain Medicine. Recurrent topics in Renu Garg's work include Pain Management and Opioid Use (7 papers), Opioid Use Disorder Treatment (7 papers) and Blood Pressure and Hypertension Studies (5 papers). Renu Garg is often cited by papers focused on Pain Management and Opioid Use (7 papers), Opioid Use Disorder Treatment (7 papers) and Blood Pressure and Hypertension Studies (5 papers). Renu Garg collaborates with scholars based in United States, India and Australia. Renu Garg's co-authors include Deborah Fulton‐Kehoe, Gary M. Franklin, Thomas R. Frieden, Lorna E. Thorpe, Kailash N. Pandey, R. Charon Gwynn, Thomas M. Wickizer, Amy M. Bauer, Mark D. Sullivan and Judith A. Turner and has published in prestigious journals such as Diabetes Care, Scientific Reports and Biochemical Journal.

In The Last Decade

Renu Garg

43 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renu Garg United States 20 364 230 192 155 108 45 977
Scott Martin Vouri United States 16 196 0.5× 117 0.5× 179 0.9× 55 0.4× 105 1.0× 87 977
Carla Truyers Belgium 15 199 0.5× 74 0.3× 163 0.8× 142 0.9× 47 0.4× 41 930
Giovanni Baglìo Italy 22 313 0.9× 87 0.4× 120 0.6× 38 0.2× 76 0.7× 111 1.4k
Cynthia Willey United States 21 238 0.7× 135 0.6× 77 0.4× 51 0.3× 76 0.7× 46 1.3k
Nancy M. Tofil United States 22 289 0.8× 59 0.3× 281 1.5× 90 0.6× 47 0.4× 74 1.6k
Cynthia Kornegay United States 11 210 0.6× 81 0.4× 119 0.6× 93 0.6× 79 0.7× 16 753
Jean‐Pascal Fournier France 18 148 0.4× 67 0.3× 84 0.4× 39 0.3× 64 0.6× 51 1.1k
Mary M. Doyle‐Waters Canada 20 278 0.8× 59 0.3× 162 0.8× 171 1.1× 46 0.4× 36 1.7k
Kristine M Schmit United States 16 86 0.2× 137 0.6× 176 0.9× 71 0.5× 28 0.3× 36 986
Barbara Broers Switzerland 19 310 0.9× 139 0.6× 655 3.4× 77 0.5× 15 0.1× 63 1.4k

Countries citing papers authored by Renu Garg

Since Specialization
Citations

This map shows the geographic impact of Renu Garg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renu Garg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renu Garg more than expected).

Fields of papers citing papers by Renu Garg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renu Garg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renu Garg. The network helps show where Renu Garg may publish in the future.

Co-authorship network of co-authors of Renu Garg

This figure shows the co-authorship network connecting the top 25 collaborators of Renu Garg. A scholar is included among the top collaborators of Renu Garg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renu Garg. Renu Garg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garg, Renu, et al.. (2023). COMPARISON BETWEEN RENOPROTECTIVE EFFECTS OF FEBUXOSTAT AND ALLOPURINOL IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERURICEMIA. Asian Journal of Pharmaceutical and Clinical Research. 54–58. 1 indexed citations
2.
Hoffman, Sarah R., Kimberly Daniels, Ryan Seals, et al.. (2023). Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study. Menopause The Journal of The North American Menopause Society. 30(8). 824–830. 6 indexed citations
5.
Garg, Renu, et al.. (2017). Unusual presentation of familial gingival fibromatosis among male siblings. Journal of Indian Society of Periodontology. 21(2). 152–152. 2 indexed citations
6.
Garg, Renu, et al.. (2016). Gingival fibroma versus verrucous leukoplakia – A clinical dilemma!!!. Journal of Indian Society of Periodontology. 20(6). 635–635.
7.
Sullivan, Mark D., Amy M. Bauer, Deborah Fulton‐Kehoe, et al.. (2016). Trends in Opioid Dosing Among Washington State Medicaid Patients Before and After Opioid Dosing Guideline Implementation. Journal of Pain. 17(5). 561–568. 39 indexed citations
8.
Fulton‐Kehoe, Deborah, Mark D. Sullivan, Judith A. Turner, et al.. (2015). Opioid Poisonings in Washington State Medicaid. Medical Care. 53(8). 679–685. 44 indexed citations
10.
Varikasuvu, Seshadri Reddy, et al.. (2014). Urban-rural differences in atherogenic dyslipidaemia (URDAD Study): a retrospective report on diabetic and non-diabetic subjects of Northern India.. PubMed. 32(3). 494–502. 4 indexed citations
11.
Garg, Renu, Deborah Fulton‐Kehoe, Judith A. Turner, et al.. (2013). Changes in Opioid Prescribing for Washington Workers' Compensation Claimants After Implementation of an Opioid Dosing Guideline for Chronic Noncancer Pain: 2004 to 2010. Journal of Pain. 14(12). 1620–1628. 45 indexed citations
12.
Gwynn, R. Charon, et al.. (2011). Peer Reviewed: Measures of Adiposity and Cardiovascular Disease Risk Factors, New York City Health and Nutrition Examination Survey, 2004. Preventing Chronic Disease. 8(3). 1 indexed citations
13.
Garg, Renu, Nicole L. Glazer, Kerri L. Wiggins, et al.. (2010). Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data. Pharmacoepidemiology and Drug Safety. 20(3). 313–316. 33 indexed citations
14.
Bornschlegel, Katherine, Magdalena Berger, Renu Garg, et al.. (2009). Prevalence of Hepatitis C Infection in New York City, 2004. Journal of Urban Health. 86(6). 909–917. 21 indexed citations
15.
Ellis, Jennifer A., Charon Gwynn, Renu Garg, et al.. (2009). Secondhand smoke exposure among nonsmokers nationally and in New York City. Nicotine & Tobacco Research. 11(4). 362–370. 48 indexed citations
16.
Gwynn, R. Charon, Hunter L. McQuistion, Katharine H. McVeigh, et al.. (2008). Prevalence, Diagnosis, and Treatment of Depression and Generalized Anxiety Disorder in a Diverse Urban Community. Psychiatric Services. 59(6). 641–647. 39 indexed citations
17.
Schillinger, Julia A., Christy M. McKinney, Renu Garg, et al.. (2008). Seroprevalence of Herpes Simplex Virus Type 2 and Characteristics Associated With Undiagnosed Infection: New York City, 2004. Sexually Transmitted Diseases. 35(6). 599–606. 32 indexed citations
18.
Nguyen, Trang, R. Charon Gwynn, Scott Kellerman, et al.. (2008). Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004. AIDS. 22(2). 281–287. 23 indexed citations
19.
Garg, Renu & Kailash N. Pandey. (2005). Regulation of guanylyl cyclase/natriuretic peptide receptor-A gene expression. Peptides. 26(6). 1009–1023. 26 indexed citations
20.
Stevenson, Lori, Renu Garg, & Jessica Leighton. (2000). Asthma hospitalization in New York city 1988–1997. Journal of Urban Health. 77(1). 137–139. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026